Salarius Pharmaceuticals Stock Analysis

Salarius Stock Analysis Notes

The company has price-to-book ratio of 0.75. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Salarius Pharmaceuticals recorded a loss per share of 5.14. The entity last dividend was issued on the 22nd of July 2019. The firm had 1:8 split on the . Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing epigenetic-based cancer treatments. It has a strategic partnership with The University of Utah Research Foundation for the exclusive license with respect to patent rights protecting SP-2577 and related compounds HLB Life Sciences to develop, produce, manufacture, use, and sell the drug in South Korea and Cancer Prevention and Research Institute of Texas for product development activities, as well as a research partnership with the Cancer Epigenetics Institute at Fox Chase Cancer Center to identify new indications and biomarkers for SP-2577. Salarius Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people. To find out more about Salarius Pharmaceuticals contact David MBA at 832 834 9144 or learn more at https://www.salariuspharma.com.

Salarius Pharmaceuticals Investment Alerts

Salarius Pharmaceuticals Upcoming and Recent Events

Salarius Largest EPS Surprises

View All Earnings Estimates

Salarius Stock Institutional Investors

Note, although Salarius Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Salarius Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.19 M.

Salarius Profitablity

Management Efficiency

Salarius Pharmaceuticals has return on total asset (ROA) of (0.5399) % which means that it has lost $0.5399 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1983) %, meaning that it created substantial loss on money invested by shareholders. Salarius Pharmaceuticals' management efficiency ratios could be used to measure how well Salarius Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.002 in 2024. Return On Capital Employed is likely to drop to -0.0026 in 2024. At this time, Salarius Pharmaceuticals' Other Current Assets are fairly stable compared to the past year. Net Tangible Assets is likely to rise to about 14.2 M in 2024, whereas Total Assets are likely to drop slightly above 6.3 M in 2024.

Technical Drivers

As of the 27th of November, Salarius Pharmaceuticals has the Risk Adjusted Performance of (0.01), coefficient of variation of (3,601), and Variance of 31.14. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Salarius Pharmaceuticals, as well as the relationship between them.

Salarius Pharmaceuticals Price Movement Analysis

Salarius Pharmaceuticals Insider Trading Activities

Salarius Pharmaceuticals Outstanding Bonds

Salarius Pharmaceuticals Predictive Daily Indicators

Salarius Pharmaceuticals Forecast Models

Salarius Pharmaceuticals' time-series forecasting models are one of many Salarius Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Salarius Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Salarius Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Salarius shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Salarius Pharmaceuticals. By using and applying Salarius Stock analysis, traders can create a robust methodology for identifying Salarius entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Salarius analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Salarius analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Salarius Pharmaceuticals stock analysis indicators help investors evaluate how Salarius Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Salarius Pharmaceuticals shares will generate the highest return on investment. By understating and applying Salarius Pharmaceuticals stock analysis, traders can identify Salarius Pharmaceuticals position entry and exit signals to maximize returns.

When running Salarius Pharmaceuticals' price analysis, check to measure Salarius Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Salarius Pharmaceuticals is operating at the current time. Most of Salarius Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Salarius Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Salarius Pharmaceuticals' price. Additionally, you may evaluate how the addition of Salarius Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.